Growth Metrics

Moderna (MRNA) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Moderna (MRNA) over the last 7 years, with Q3 2025 value amounting to 0.18.

  • Moderna's Asset Utilization Ratio fell 4197.9% to 0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year decrease of 4197.9%. This contributed to the annual value of 0.2 for FY2024, which is 3574.59% down from last year.
  • Latest data reveals that Moderna reported Asset Utilization Ratio of 0.18 as of Q3 2025, which was down 4197.9% from 0.25 recorded in Q2 2025.
  • Moderna's 5-year Asset Utilization Ratio high stood at 0.86 for Q1 2022, and its period low was 0.18 during Q3 2025.
  • Over the past 5 years, Moderna's median Asset Utilization Ratio value was 0.44 (recorded in 2023), while the average stood at 0.48.
  • Per our database at Business Quant, Moderna's Asset Utilization Ratio soared by 117357.8% in 2021 and then plummeted by 5134.82% in 2024.
  • Moderna's Asset Utilization Ratio (Quarter) stood at 0.81 in 2021, then dropped by 8.41% to 0.74 in 2022, then crashed by 51.27% to 0.36 in 2023, then tumbled by 41.43% to 0.21 in 2024, then fell by 12.7% to 0.18 in 2025.
  • Its Asset Utilization Ratio was 0.18 in Q3 2025, compared to 0.25 in Q2 2025 and 0.23 in Q1 2025.